For the first time, UCL researchers have used AI to identify two biologically distinct forms of MS, supporting the potential for more personalised care and improved treatment decisions for patients ...
Annual out-of-pocket costs for multiple sclerosis (MS) care in the US increased by 125% from 2002 to 2021, primarily driven by newer disease-modifying therapies (DMTs), a new study showed. Researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback